Queen's leads €50 million program to develop new antibiotics for cystic fibrosis and bronchiectasis

(Queen's University Belfast) The iABC (inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis) consortium, which is made up of world-leading lung specialists from across Europe, will develop new 'inhaled antibiotics' to manage chronic lung infection, the main cause of disease and death in patients with cystic fibrosis and bronchiectasis.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news